Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2021 | Benefits of a virtual EHA 2021 meeting

Andrew Brunner • 3 Jun 2021
EHA 2021
General

Andrew Brunner, MD, Massachusetts General Hospital, Boston, MA, discusses what he’s looking forward to at EHA 2021. This interview took place at the virtual European Hematology Association (EHA) Congress 2021.

Disclosures

Andrew M. Brunner, MD, has participated in consultancy work for Novartis, Acceleron, Agios, BMS/Celgene and Takeda.

More from Andrew Brunner

iwMDS wrap-up: translating research into practice to optimize patient care
23:22
iwMDS wrap-up: translating research into practice to optimize patient care
Amer Zeidan et al. • 29 Jun 2025
Advances in the treatment of LR-MDS: luspatercept combinations, the use of imetelstat & more
5:17
Advances in the treatment of LR-MDS: luspatercept combinations, the use of imetelstat & more
Andrew Brunner et al. • 28 Jun 2025
The oral ATR inhibitor ceralasertib in patients with MDS or CMML
3:03
The oral ATR inhibitor ceralasertib in patients with MDS or CMML
Andrew Brunner • 9 Dec 2024
Real-world effectiveness of midostaurin versus quizartinib in FLT3-ITD mutated AML
1:54
Real-world effectiveness of midostaurin versus quizartinib in FLT3-ITD mutated AML
Andrew Brunner • 9 Dec 2024

Related Videos

The ethical challenges of AI in hematology: patient communication, trust and regulation
3:12
The ethical challenges of AI in hematology: patient communication, trust and regulation
Adrián Mosquera Orgueira • 24 Sep 2026
The future of AI in hematology: personalized medicine, opportunities and risks
2:30
The future of AI in hematology: personalized medicine, opportunities and risks
Adrián Mosquera Orgueira • 24 Sep 2026
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
5:18
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
Shyam Patel • 13 Oct 2026
The scientific and clinical implications of therapy-related CHIP in oncology
2:43
The scientific and clinical implications of therapy-related CHIP in oncology
Shyam Patel • 13 Oct 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals